Proposal acronym: CAPTIVATE
Project ID: 101081028
Typ of action: HADEA
Topic: HORIZON-HLTH-2022-DISEASE-06-03-two-stage
Call: HORIZON-WIDERA-2023-ACCESS-06-01
Implementation date: 1. 11. 2023 – 30. 4. 2028
Budget: 8 185 948 € (FGU 505 000 €)
Project content:
The CAPTIVATE project aims to develop a more effective vaccine against Plasmodium falciparum, the causative agent of one of the most dangerous forms of malaria. It employs a combination of approaches targeting different developmental stages of the parasite (sporozoite, liver, and blood stages), including advanced mRNA technologies, attenuated parasites, and the already approved RTS,S/AS01 vaccine. In addition to preclinical and clinical testing, the project also places strong emphasis on a deep understanding of the immune mechanisms that lead to protection against infection. This project is funding from the European Union’s Horizon Europe Framework Programme (HORIZON) undergrant agreement No. 101081028
More information about project
